key: cord-0721698-em2azrec
authors: Liang, Julia; Pitsillou, Eleni; Burbury, Lucy; Hung, Andrew; Karagiannis, Tom C
title: In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex
date: 2021-04-09
journal: Chem Phys Lett
DOI: 10.1016/j.cplett.2021.138618
sha: e8d9cd3fd2e9df57e18421ee2037cbe72900cc48
doc_id: 721698
cord_uid: em2azrec

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in an international health emergency. The SARS-CoV-2 nsp16 is an S-adenosyl-L-methionine (SAM)-dependent methyltransferase, and with its cofactor nsp10, is responsible for RNA cap formation. This study aimed to identify small molecules binding to the SAM-binding site of the nsp10-nsp16 heterodimer for potential inhibition of methyltransferase activity. By screening a library of 300 compounds, 30 compounds were selected based on binding scores, side-effects, and availability. Following more advanced docking, six potential lead compounds were further investigated using molecular dynamics simulations. This revealed the dietary compound oleuropein as a potential methyltransferase inhibitor.

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to pose significant public health concerns, having caused millions of infections worldwide and devastating global economies (1) . The development of a safe and effective vaccine against COVID-19 remains a priority, with a global effort culminating in numerous clinical trials underway (2) . There has also been interest in the investigation of potential prophylactic and therapeutic compounds, with drug repurposing presenting an expedited avenue of COVID-19 suppression through utilising existing medications for which dosages and side effects are known. Remdesivir, an inhibitor of the viral RNA-dependent RNA polymerase, was approved by the Food and Drug Administration (FDA) for emergency use authorisation of hospitalised COVID-19 patients with severe disease (3) . However, clinical trial data has shown that benefits of remdesivir were modest to none on survival, particularly for moderately ill patients (4, 5) . More controversially, the emergency use authorisation of the antimalarial drug hydroxychloroquine for treating patients with COVID-19 was initially provided, and then revoked following findings it was ineffective in reducing mortality (6) . In the absence of an efficacious treatment for COVID-19, a greater understanding of the pathogenesis and potential interventions is required.

Coronaviruses are a family of enveloped positive-sense single-stranded RNA viruses belonging to the family Coronaviridae (7) . Human coronaviruses, such as HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, are known to circulate in the population and are mildly pathogenic, causing seasonal common cold-like symptoms (7) . Conversely, the highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory virus syndrome coronavirus (MERS-CoV) epidemics emerged in 2003 and 2012 respectively, with infections that can develop into life-threatening pathologies (7, 8) . While the closely related SARS-CoV-2 has a lower mortality rate, it has a far higher transmissibility leading to difficulties in containment (8) .

The genome of SARS-CoV-2 has ~29,800 bases, with 14 open reading frames (ORFs) encoding four structural and 16 non-structural proteins (nsp1 to nsp16) (9) . At the 5' terminus of the genome, the ORF1ab and ORF1a genes encode polyproteins pp1ab and pp1a, while the 3'-terminus encodes four major structural proteins, including the spike surface glycoprotein (9) . Following entry of SARS-CoV-2 into the host cell, the polyproteins are translated and processed into the 16 nsps, 15 of which are assembled into the replication transcription complex (RTC) (7) . The RTC assembly is comprised of enzymes that maintain the integrity of the coronavirus genome through regulating RNA proofreading, as well as RNA-processing and RNA-modification (7) . Within this complex, nsp14 and nsp16 are responsible for capping viral mRNA, which serves the critical function of avoiding innate immune recognition by the host (10) . In concert with nsp10, nsp16 converts mRNA species from a Cap-0 to Cap-1 structure through 2'-O methylation of the first transcribed nucleotide (11) . This process is dependent on the use of S-adenosyl-L-methionine (SAM) as the methyl donor (12) . Nsp10 is a necessary cofactor for nsp16 function, inducing a conformational change to stabilise the SAM-binding pocket (13) .

In addition to synthesised drugs, there has been interest in the investigation of antiviral activity of naturally-occurring compounds derived from dietary sources (14) . Extra-virgin olive oil is the principal source of dietary fat in the Mediterranean diet, with bioactive properties attributable to its phenolic compound content (15) . It is hypothesised that small molecules may potentially inhibit methyltransferase activity of the SARS-CoV-2 nsp10-nsp16 complex by binding to the SAM-binding site. The SARS-CoV-2 nsp16 has been an attractive target for small molecule inhibition (16) . In the present study, we screened a library of 300 ligands for potential inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex using molecular docking. A majority of these compounds were derived from the olive, consisting of 220 phenolic compounds and 13 fatty acids obtained from the OliveNet TM Library, as well as a selection of additional small molecules with known antiviral, antioxidant, and antiinflammatory activities (17) . Via molecular docking studies, we identified several lead compounds that may be suitable for further analysis as potential inhibitors of SARS-CoV-2 methyltransferase activity.

The crystal structure of the SARS-CoV-2 nsp10-16 methyltransferase complex was obtained from the RCSB Protein Data Bank (PDB ID: 6YZ1) (13) . Crystallographic waters and ligands were removed, and the native zinc ions were retained. 300 small molecules were chosen for investigation against the nsp10-nsp16 methyltransferase complex. 233 of these were obtained from the OliveNet TM Library (17), including 220 phenolic compounds and 13 fatty acids.

Additional ligands included known protease inhibitors and antibiotics, and compounds with proven antiviral, antioxidant and anti-inflammatory properties (18) (19) (20) (21) (22) (23) (24) (25) . Compounds that were screened against the nsp10-nsp16 methyltransferase complex are listed in Table S1 . Ligand structures were obtained from the National Centre for Biotechnology Information PubChem database (26) . Chem3D 19.0 (Perkin Elmer, Massachusetts, USA) was used to draw unavailable ligand structures.

Structure preparation and molecular docking was performed using the Schrödinger Suite (version 2020-2) molecular modelling package. The nsp10-nsp16 methyltransferase complex was prepared using the Protein Preparation Wizard, and ligands were processed using LigPrep.

Initial screening of all 300 compounds utilised Glide for molecular docking with the standard precision mode (SP) selected. Docking was performed using default settings, utilising the OPLS3e force field. The receptor grid was centred around the co-crystallised sinefungin and was 20 x 20 x 20 Å in size. 30 compounds were selected for further analysis based on binding affinity, known side effects, and availability.

For the top 30 compounds, molecular docking was subsequently performed using the quantummechanics-polarised ligand docking (QPLD) protocol of the Schrödinger Suite as previously described (27, 28) . The receptor grid was centred around the co-crystallised sinefungin and was 20 x 20 x 20 Å in size.

The PrankWeb server was used to identify potential ligand binding sites in the nsp10-nsp16 protein complex (29) . Blind docking of 30 compounds selected based on initial screening was performed using AutoDock Vina (30) . The receptor grid encompassed the entire surface of the heterodimer, and docking was performed at an exhaustiveness of 2048. Blind docking calculations were performed using cloud computing services provided by Galileo (Hypernet Labs) (31).

Classical MD simulations with SARS-CoV-2 nsp10-nsp16 methyltransferase complex bound with small molecules were performed as previously described (27) Systems were fully solvated with TIP3P water in a dodecahedral box, with a minimum distance of 2.0 nm between protein atoms and the closest box edge. Simulations were performed with a time-step of 2 fs in triplicate for 200 ns, with trajectories totalling 3.6 µs across six separate systems. Root mean square fluctuation (RMSF) and contacts analysis was calculated for each complex between 50 to 100 ns of the stabilised trajectories. The number of contacts between the ligand and protein complex was calculated using gmx mindist, with a threshold of 0.45 nm used to define a contact between the ligand and protein residue (32, 33) .

Mediated by the nsp10-nsp16 heterodimer, 2'-O-methylation is essential for RNA cap formation in SARS-CoV-2, which is critical for evading immune response in the host (36) .

Thus, the nsp10-nsp16 methyltransferase complex is an attractive target for small molecule inhibition. The crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with sinefungin, a pan-methyltransferase inhibitor, has been reported by Krafcikova et al., and was utilised in this study (13) . The co-crystallised sinefungin and the methyl donor SAM were used as controls.

The structure of the nsp10-nsp16 heterodimer is shown in Figure 1A . Nsp10 is a necessary cofactor for the proper function of the methyltransferases nsp14 and nsp16 (11) . Nsp10 contains two zinc binding sites, which stabilises helices α2 and α3, and the C-terminus of nsp10 (13) . Upon binding to nsp10, nsp16 promotes binding to the methyl donor SAM and capped RNA substrate (12) . The transfer of the methyl group from SAM to Cap-0 is catalysed by nsp16, to generate the reaction products S-adenosylhomocysteine (SAH) and Cap-1.

Sinefungin binds within the SAM-binding pocket to inhibit this reaction, and is used as a paninhibitor of methyltransferases (37) . Figure 1B depicts the top ranked potential ligand binding sites on the surface of the nsp10-nsp16 heterodimer using the PrankWeb server (29) . The top ranking pocket depicted yielded a binding site score of 20.7, compared to pockets ranked 2 to 9 having Site scores of less than 5. It is noted that the top ranked predicted ligand binding site encompasses the SAM-binding site, as well as extending into a groove that encroaches into the RNA binding groove. The predicted ligand binding site encompasses several residues involved in the stabilisation of RNA cap binding, such as Cys25, Tyr30, Lys137, and Ser202 (38) .

In order to identify potential inhibitors, a library of 300 compounds were screened in this study using molecular docking. This library consisted of a combination of dietary compounds and known antivirals. An emphasis was placed on dietary compounds, particularly on phenolics from the OliveNet TM Library, a database of compounds derived from olea europaea we previously curated (17) . The 300 compounds were docked to the SAM-binding site of nsp16 in the heterodimer using Glide, with binding affinities shown in Table S1 .

Based on binding affinities, known side effects, and availability, 30 compounds were selected for further investigation. The structures of these compounds are shown in Table S2 . A more in- Table 1 .

Taking together the docking and blind docking results, 6 lead compounds were identified that may serve as the basis for further investigation as potential methyltransferase inhibitors. These were the antivirals lopinavir and ritonavir, and the dietary compounds oleuropein, oleacein, cyanidin-3-O-glucoside, and epigallocatechin gallate (EGCG). QPLD docking results are shown in Figure 2 for the controls and antivirals, and Figure 3 for the lead dietary compounds.

The blind docking results for controls and antiviral compounds can be seen in Figure 4 , and blind docking results for dietary compounds in Figure 5 .

SAM is the methyl donor substrate necessary for 2'-O methylation activity in nsp16, while sinefungin is a pan-methyltransferase inhibitor initially isolated from Streptomyces griseoleus (13, 40) . Both these compounds were utilised as controls in the present study. In principal, small molecules binding with a greater affinity compared to SAM may be potential methyltransferase inhibitors.

From the QPLD docking results, SAM binds with a GlideScore of -9.6 kcal/mol, while sinefungin produced a slightly stronger score of -10.2 kcal/mol, in line with its known activity as a methyltransferase inhibitor ( Figure 2 ). Following docking to the SAM-binding site, sinefungin and SAM were observed to form hydrogen bonds with several highly conserved residues among SARS-CoV-2, SARS-CoV, and MERS, namely Asn43, Asp99, Asp114, (13) . Nsp16 contains the highly conserved canonical catalytic K-D-K-E motif comprising of residues Lys46, Asp130, Lys170, and Glu203 (11, 37, 41) . This catalytic tetrad is in proximity to the SAM methyl group that is transferred to the 2'-OH on the methylated Cap-0 (37) . It is noted that as well at both SAM and sinefungin forming interactions with Asp130, sinefungin also formed a hydrogen bond with the catalytic Lys170. 

Lopinavir-ritonavir has been studied as an antiviral treatment for patients with COVID-19 in clinical trials (42, 43) . Lopinavir is a HIV-1 protease inhibitor, usually combined with ritonavir to increase plasma concentration and efficacy (42, 43) . Lopinavir is an inhibitor of the SARS-CoV main protease, an enzyme necessary for viral replication and is highly conserved in SARS-CoV-2 (42, 43) . Ritonavir is another protease inhibitor, inhibiting hepatic cytochrome P450 activity to increase plasma half-life (42) . While lopinavir/ritonavir has not been recommended as a treatment for COVID-19 beyond the context of clinical trials, the identification of these compounds as strong binders suggest that they may potentially have methyltransferase inhibition activity in addition to their known protease inhibitory properties.

Lopinavir and ritonavir bound to the SAM-binding site with GlideScores of -8.0 and -6.1 kcal/mol respectively (Figure 2 ). Both compounds were observed to form hydrogen bonds with the conserved Asp99, lopinavir forming a hydrogen bond with the conserved Asn101 (13) . 

Oleuropein and oleacein are dietary compounds derived from the olive, classified as secoiridoids (17) . Oleuropein is one of the main polyphenolic constituents of olive oil and is widely recognised in the literature for its potent antioxidant activity and anti-inflammatory activity, with pharmacological activity in a wide range of diseases (44) . Oleacein has been suggested to possess methyltransferase inhibitory activity, functioning as a dual substrateinhibitor of catechol-O-methyltransferase for potential anticancer activity (45) . It has also been hypothesised that oleacein may act as an inhibitor of lysine-specific histone demethylase 1A (LSD1), an epigenetic regulator of metabolic disorders and cancer (46) . QPLD docking revealed that oleuropein was among the strongest binding compounds to the SAM-binding site, with a GlideScore of -11.1 kcal/mol; stronger than the positive controls ( Figure 2 and Figure 3 ). Hydrogen bonds were observed to form with the conserved Asn43 and Asn101, as well as with three of the four catalytic dyad residues: Lys46, Asp130, and Lys170 (13, 38) . Additionally, 18 out of 20 poses were shown to bind to the SAM-binding pocket ( Figure 5 ). These results suggest that oleuropein may be a strong lead warranting further investigation. Oleacein bound to the active site with a GlideScore of -7.9 kcal/mol, forming hydrogen bonds with Cys115, Tyr132, and the conserved Asp114 (13) . From blind docking, 9 out of 20 poses for oleacein were binding to the SAM-binding pocket, with the top ranked pose binding with a similar affinity to that of oleuropein (-6.9 and -6.8 kcal/mol for oleacein and oleuropein, respectively) ( Figure 5 ).

Cyanidin-3-O-glucoside and EGCG are also dietary derived compounds that were identified as leads with potential inhibition of methyltransferase activity. Cyanidin-3-O-glucoside is found in a variety of fruits and legumes, and is the main active anthocyanin in blueberry extracts (17, 47) . Cyanidin-3-O-glucoside has been reported to have potential benefits in a variety of inflammatory diseases and cancer, including the attenuation of acute lung injury in rats with sepsis (47) . EGCG is an abundant catechin found in green tea, and has been heavily studied as for its antioxidant and chemopreventative properties (48) . 

To assess the stability of lead compounds bound to the SAM-binding pocket of SARS-CoV-2 nsp10-nsp16 methyltransferase complex, MD simulations were performed in triplicate for 200 ns (Figures 6 and 7) . A total of six different systems were studied: the apo protein complex, and the protein complex bound with the control compound sinefungin, and dietary compounds oleuropein, oleacein, cyanidin-3-O-glucoside, and epigallocatechin gallate (Movies S1 -S7).

While molecular docking data suggested that all studied compounds were potential leads, Figure 6C and 7C). The greatest fluctuations were observed at terminal regions of each chain of the protein complex, which can also be observed visually (Movies S1 -S7). The most prominent protein flexibility was for all systems were located at residues 20 -40 and 133 -143 of nsp16. These residues are located within gate loops 1 and gate loop 2 regions of the protein respectively, which function to stabilise RNA cap binding (38) . The flexibility of these residues is further highlighted in Figures 6D and 7D , which show the difference in RMSF values of the protein backbone of ligand-bound systems following subtraction of apo values.

The sinefungin-bound methyltransferase complex demonstrates a difference in RMSF of -0.10 nm at residue Asn29 and -0.09 nm at residue Val139. For oleuropein, a difference in RMSF of +0.12 nm was observed at Ser33. Epigallocatechin gallate-bound nsp16 demonstrated a difference in RMSF of +0.09 at Thr25. The cyanidin-3-O-glucoside-bound protein shows a difference in RMSF of +0.10 at Lys137 and -0.07 nm at Lys141. Another flexible region of the protein was at Arg216 and Glu217 of nsp16, which lies on the surface of the protein near the methyltransferase core (38) .

The average number of contacts over 50 ns of the stabilised trajectories between the bound ligand and protein residues was calculated in triplicate. A greater number of contacts were observed overall for sinefungin and oleuropein ( Figure 6B ) compared to the remaining dietary compounds oleacein, cyanidin-3-O-glucoside, and epigallocatechin gallate ( Figure 7B ). This can be attributed ligand unbinding events for the latter dietary compounds. For instance, cyanidin-3-O-glucoside was detached from the protein complex after approximately 50 ns in all three replicates and remained unbound in the solvent (Movie S5). This is demonstrated by a marked reduction in the number of contacts between the protein complex and cyanidin-3-Oglucoside ( Figure 7B ). Ligand unbinding was also observed with oleacein in all three replicates, yielding a lower number of contacts with protein residues overall. Interestingly, oleacein was observed to detach from the SAM-binding site in one simulation, before re-attaching at distal sites along the protein surface (Movie S4). This is reflected by contacts with Phe245 and Arg255 in Figure 7B , which is in line blind docking results ( Figure 5 ). Compared to the other dietary compounds oleacein had a lower number of poses in the SAM-binding pocket, with these residues in the proximity to the top ranked blind docking poses.

Epigallocatechin gallate which remained bound to the SAM-binding site in two replicates, demonstrates similar contacts with the most prominent residues that were making contacts with sinefungin and oleuropein. These included Leu100 (38 contacts), and gate loop 2 residues Tyr132 (42.5 contacts) and Pro134 (41.1 contacts). As mentioned above, sinefungin and oleuropein were strongly bound to the SAM-binding site of the nsp10-nsp16 protein complex for the entire trajectory. The main contacts observed with sinefungin were 46.8 contacts with Asp75 and 41.1 contacts with Lys135. Oleuropein formed the greatest number of contacts with residues Leu100 and Pro134, with an average number of 80.2 and 51.1 contacts throughout the 50 ns segment of the trajectory, respectively. These residues are involved in facilitating a favourable orientation of SAM for 2'O-methylation, suggesting that binding of oleuropein to these residues may potentially inhibit methyltransferase activity in SARS-CoV-2 nsp16 (38) .

Regarding the catalytic tetrad residues of nsp16, sinefungin was the only ligand to consistently form contacts with these residues throughout the analysed trajectory. There was an average of 14.5 contacts with Lys46, 20.4 contacts with Asp130, 30.1 contacts with Lys170, and 2.4 with Glu203. All the dietary compounds were in minimal contact with these catalytic residues.

While this shows that sinefungin is a strong control for inhibition of methyltransferase activity, it should be noted that it has not been developed for clinical use due to severe toxic side effects in dogs and goats (49, 50) . Oleuropein, on the other hand, has been well-studied for its biological and pharmacokinetic properties as the most prominent phenolic compound found in olives (44) . Taking together molecular docking and MD simulation data from the present study, oleuropein may be a strong candidate warranting further evaluation as a potential inhibitor of methyltransferase activity in SARS-CoV-2.

Overall, a library of 300 compounds was screened for potential inhibitory properties against the nsp10-nsp16 methyltransferase complex. From a selection of 30 compounds based on binding affinity, availability, and known side effects, a more detailed docking study identified six lead compounds. These were the antiviral compounds lopinavir and ritonavir, and the dietary compounds oleuropein, oleacein, cyanidin-3-O-glucoside, and epigallocatechin gallate.

MD simulations of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex bound with the lead dietary compounds identified oleuropein as a potential inhibitor, requiring further evaluation using in vitro studies are for antiviral effects.

TCK and AH conceptualized the aims and methodology and were involved in supervision. JL performed formal data analysis, was involved in data curation, and contributed to writing the original draft. LB performed formal data analysis, was involved in data curation, and contributed to writing the original draft. EP performed formal data analysis and was involved in data curation. All authors contributed to editing and reviewing the manuscript. properties, namely hydrophobic residues (green), negatively charged residues (red), positively charged residues (blue), and glycine residues (pink). Compounds were docked to the SAM-binding site using the QPLD protocol, with GlideScores shown. Blind docking was performed to generate a maximum of 20 poses. The number of generated poses located in the SAM-binding site are listed, as well as its strongest ranked binding affinity. SAM and sinefungin were used as controls. Table S1 : Molecular docking of 300 compounds to nsp10-nsp16 methyltranferase complex SAM-binding site. Highlights  The SARS-CoV-2 nsp10-nsp16 methyltransferase is required for viral RNA stability  Initial screen of 300 small molecules to nsp16 S-adenosylmethionine-binding site  In-depth molecular docking study of top 30 compounds based on initial screen  Six lead compounds including lopinavir/ritonavir and cyanidin glucoside identified  MD simulations reveal oleuropein as a potential methyltransferase inhibitor

The socioeconomic implications of the coronavirus pandemic (COVID-19): A review

COVID-19 Vaccine: A comprehensive status report

COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment

Remdesivir for the Treatment of Covid-19 -Final Report

Covid-19: Remdesivir has little or no impact on survival, WHO trial shows

Emergency Use Authorizations During the COVID-19

Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval

Coronavirus biology and replication: implications for SARS-CoV-2

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet Infectious diseases

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

mRNA capping: biological functions and applications

Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex

Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex

Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin

Antiviral activity of plants and their isolated bioactive compounds: An update

Mediterranean diet and health: biological importance of olive oil

Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study

OliveNet™: a comprehensive library of compounds from Olea europaea

Proteases and protease inhibitors in infectious diseases

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review

Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination

Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

Curcumin, a component of golden spice: from bedside to bench and back

The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases

Potential therapeutic targets and promising drugs for combating SARS-CoV-2

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

PubChem 2019 update: improved access to chemical data

Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex

Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface

PrankWeb: a web server for ligand binding site prediction and visualization

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

A message-passing parallel molecular dynamics implementation

High performance molecular simulations through multi-level parallelism from laptops to supercomputers

Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles

SwissParam: a fast force field generation tool for small organic molecules

mRNA cap-1 methyltransferase in the SARS genome

High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design

Structural basis of RNA cap modification by SARS-CoV-2

Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach

A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation

Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Oleuropein in olive and its pharmacological effects

The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-Omethyltransferase. Food and chemical toxicology : an international journal published for the British Industrial

Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A

Cyanidin-3-O-glucoside attenuates acute lung injury in sepsis rats

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

Evaluation of sinefungin for the treatment of Trypanosoma (Nannomonas) congolense infections in goats. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ)

new antitrypanosomal antibiotics produced by Streptomyces sp. K05-0178

We would like to acknowledge intellectual and financial support by McCord Research (Iowa, USA). JL is supported by an Australian Government Research Training Program Scholarship.We are indebted to Alfonso Perez Escudero and the team at Crowdfight COVID-19 for

TCK and AH conceptualized the aims and methodology and were involved in supervision. JL performed formal data analysis, was involved in data curation, and contributed to writing the original draft. LB performed formal data analysis, was involved in data curation, and contributed to writing the original draft. EP performed formal data analysis and was involved in data curation. All authors contributed to editing and reviewing the manuscript.